PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “ANTIDEPRESSIVE AGENTS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 595 records · Page 33Linked to original sources

[Disposition of the potential antidepressive agent (3H) VUFB 15468 in mice and rats].

Excretion, biodistribution and pharmacokinetics of the above-mentioned drug after oral doses of 10 and 50 mg/kg were investigated. The drug is completely and rapidly resorbed from the digestive tract. It shows relatively large renal and metabolic clearance, it is extensively distributed in the tissues This results in its rapid elimination from plasma (t1/2 approximately 3 h) and, on the other hand, higher concentrations of radioactive drugs in tissues. Penetration and specific binding of VUFB 15468 in the murine brain in dependence on the administered dose were tested (ED50 approximately 4 mg/kg). Autoradiographic examination of the rat brain demonstrated an increased concentration of radioactive drugs in the cerebral cortex, hippocampus, hypophysis and central ganglia.

Animals↗

[Hemodynamic and electrocardiographic effects caused by intravenous infusion of a tricyclic antidepressive agent dibenzepin].

The cardiovascular (blood pressure, heart rate, central venous pressure) and ECG changes caused by dibenzepine-infusion (720 mg/day for 48 hours) have been assessed. Mean blood pressure and heart rate did not show significant changes. In some patients, however, distinct changes in both variables were observed. Central venous pressure was not affected. The infusion elicited changes in the repolarisation phase of the ECG: it did not, however, alter either the automaticity or the conductivity of the heart. These results were obtained in 40 depressive patients, whose general conditions and cardiovascular state were excellent and must not be extrapolated for cardiopathic patients. The risks inherent in this therapeutic approach are discussed.

Adolescent↗